PAD pt 1 Flashcards

1
Q

The presence of a stenosis or occlusion in the aorta or arteries of the limbs

A

Peripheral Arterial Disease (PAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Peripheral Arterial Disease (PAD) is MCC by?

A

atherosclerosis in >40 y/o

Other potential causes: thrombosis, embolism, vasculitis, fibromuscular dysplasia, entrapment, cystic adventitial disease, and trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PAD can occur in any limb but MC affects ?

A

lower extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical Manifestations of PAD

A
  1. Carotid Artery Disease
    - TIA
    - Cerebrovascular accident
  2. CAD
    - stable angina pectoris
    - ACS
  3. Renovascular Disease
    - HTN
    - renal insufficiency
  4. PAD
    - intermittent claudication
    - critical limb ischemia

Associated with increased risk of CV and cerebrovascular events (MI, stroke, death)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pathology of PAD

A
  1. Atherosclerotic plaques with calcium deposits
  2. Thinning of the media
  3. Patchy destruction of muscle and elastic fibers
  4. Fragmentation of internal elastic lamina
  5. Thrombus development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Segmental lesions in PAD typically localized to what type of vessels

A

large or medium-size vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Primary sites where PAD is involved:

A
  • Abdominal aorta and iliac arteries (30% of sx pts)
  • Femoral and popliteal arteries (80-90% of pt)
  • Tibial and peroneal arteries (40-50% of pt)
  • Lesions at arterial branch points - D/t increased turbulence, altered shear stress, & intimal injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Risk Factors for PAD

A
  • Smoking
  • Diabetes Mellitus
  • Hypercholesterolemia
  • Hypertension
  • Renal Insufficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prevalence of PAD is 30% for patients who are what ages?

A
  • ≥70 y/o without RF
  • ≥50 y/o with RF present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACC/AHA recommends patients in the following categories be evaluated for PAD:

A
  • ≥70 y/o
  • 50-69 y/o with h/o smoking or DM
  • 40-49 with DM and ≥ 1 other risk factor for atherosclerosis
  • Known atherosclerosis at other sites (coronary, carotid, renal, mesenteric or AAA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The location of atherosclerosis has its own population demographic, name the 3:

A
  1. Distal aorta & proximal common iliac (30% of symptomatic pts)
    - White, male smokers aged 50-60 years
  2. Femoral-popliteal (80-90%)
    - ≥ age 60, no gender
    - Blacks and Hispanics
  3. Tibial artery (40-50%)
    - MC DM and elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PAD Clinical Presentations

A
  1. asx (20-50%)
  2. atypical leg pain (40-50%)
  3. classic claudication (10-35%)
  4. critical limb ischemia (1-2%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most typical symptom of PAD
pain, aching, cramping, numbness, or muscle fatigue that occurs during exercise and is relieved by rest within 10 min of cessation

A

intermittent claudication

Can occur in the buttocks, thigh, calf or foot depending on level of vessel occlusion - occur distal to sight of occlusive lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Beware of ___, which can mimic true PAD induced claudication

A

pseudoclaudication/neurogenic claudication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MCC of neurogenic claudication

A
  1. Spinal canal stenosis
  2. Herniated disc impingement on sciatic nerve
  3. Other: Peripheral neuropathy, peripheral nerve pain, OA of the hip/knee, venous claudication, chronic compartment syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • Same, tingling, burning, numbness
  • locations of discomfort is the same
  • Sometimes exercised induced
  • distance of claudication is variable
  • Occurs with standing
  • Relieved when sitting, or change position
  • Takes up to 30 minutes

what type of claudication

A

Pseudoclaudication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  • Cramping, tightness, aching, fatigue
  • Location of discomfort usually buttock, hip, thigh, calf, foot
  • Always induced by exerise
  • Distance of discomfort is consistent
  • Does not occur with standing
  • Relieved while standing
  • Relieved in less than 5 minutes

what type of claudication

A

actual claudication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

PAD patients with tibial and pedal artery disease may do not have claudication, what other signs may they present?

A
  • Rest pain / ulceration may be the first sign of vascular insufficiency
  • Classically, rest pain is confined to the dorsum of the foot and is relieved with dependency
  • Can progress to critical limb ischemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Clinical Classification systems for PAD is based on ____
What are these systems?

A

anatomic distribution of lesions

  • Trans-Atlantic Inter-Society Consensus (TASC II) - MC
  • Global Limb Anatomic Staging System (GLASS) Classification - Has yet to be validated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Limb Staging in Chronic Lower Extremity Ischemia

A
  • Rutherford classification
  • Fontaine classification
  • Society for Vascular Surgery (SVS) Lower Extremity Threatened Limb Classification System to Stratify Amputation Risk, Wound, Ischemia and foot Infection (WIfI) - Has replaced Rutherford and Fontaine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how to approach a suspected PAD pt

A
  • Pulse exam - Carotid, Brachial, Radial/Ulnar, Femoral, Popliteal, Dorsalis pedis, Posterior tibial
  • PE - BP in bilateral arms, CV, Abdomen (AAA), auscultation for bruits, skin (legs & feet)
  • Skin temperature with dorsum of hand
  • Skin visualization
  • Hair distribution
  • Nails
  • Lower extremity musculature (measure leg circumference for accuracy)
  • Bony anatomy of feet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

grading of pulses

A
  • 3+ Bounding
  • 2+ brisk, expected (normal)
  • 1+ diminished, weaker than expected
  • 0 absent, unable to palpate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Classic finding of pulse eval in PAD

A

Decreased or absent pulses distal to the obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PE findings in PAD

A
  • Reduced skin temp / cool
  • Smooth, shiny with pallor or cyanosis; ulceration
  • Distal hair loss, typically over ankles, calves
  • Thickened
  • Calf atrophy
  • Abnormality, especially in diabetics (charcot arthropathy)
  • Leg lift test - pallor occurs if arterial pressure is not adequate to overcome gravity
  • Dependent rubor
25
Q

what is the leg lift test

A
  • Elevate leg to 60° for 1 minute
  • (+) test = pallor occurs if arterial pressure is not adequate to overcome gravity
  • Repetitive dorsiflexion and plantar flexion of the foot may precipitate pallor of the sole of the foot
26
Q

how to assess for dependent rubor

A
  • Evaluate when pt becomes seated after being supine
  • Qualitatively assesses collateral blood flow
  • Time to the development of dependent rubor is indicative of severity of PAD
27
Q

best screening tool for PAD is ?

A

Ankle Brachial Index

  • Objective assessment of the presence and severity of disease
  • Easily performed with no risk to patient
  • Can be performed at bedside
  • placement of sphygmomanometric cuffs at ankles and use of a Doppler to auscultate or record blood flow from dorsalis pedis and posterior tibial arteries
28
Q

how to dx PAD?

A

MC - ABI + H&P

Further testing is only needed if ABI shows false negative or if invasive intervention is planned

29
Q

Who Should Be Screened for PAD

A
  • Pt with H&P findings suggestive of PAD, ABI is recommended (Class I LOE B)
  • Pt at increased risk of PAD but without H&P findings suggestive of PAD, ABI is reasonable (Class IIa, LOE B)
29
Q

interpretations of ABI

A
  • > 1.40 - Non-compressible vessel
  • 1.40 - 1.00 - Normal
  • 0.99 - 0.91 - Borderline
  • 0.90 - 0.70 - Diagnostic of PAD / Mild
  • 0.69 - 0.40 - Moderate
  • <0.40 - Severe
30
Q

ABI Limitations

A
  1. Incompressible arteries
  2. Resting ABI may be insensitive or in pts who are well collateralized
    - Normal resting values in symptomatic pts may become abnormal after exercise
  3. Not for degree of functional limitation
  4. Does not define location of disease
31
Q

What type of pts may have incompressible arteries that limit for use of ABI

A
  • Elderly
  • diabetes
  • renal failure
  • patients on chronic steroids
32
Q

types of noninvasive imaging

A
  1. toe brachial index (TBI)
  2. treadmill exercise test
  3. segmental limb pressure
  4. Arterial Duplex Ultrasonography
  5. MR Angiogram (MRA) & CT Angiography (CTA)
33
Q
  • Screening – useful when ABI is >1.40 (non-compressible) - Digital vessels spared from medial arterial disease
  • Helps predict wound healing

what noninvasive imaging is this

A

TBI

34
Q

interpretations of TBI

A
  • Higher values predict better healing
  • TBI = (Toe systolic pressure)/(Highest brachial systolic pressure)

TBI <= 0.70 = abnormal and dx of PAD

35
Q
  • Assesses functional capacity
  • Measures the distance a claudicator can walk at baseline
  • Can clarify if a patient’s sx are related to PAD - typical sx but resting ABI normal; atypical sx but patient has PAD

what noninvasive imaging is this

A

Treadmill Exercise Test

36
Q

when to not use Treadmill Exercise Test

A
  • non-compressible vessels
  • Cannot walk on treadmill (unstable angina, gait instability, etc.)
37
Q

Patient then walks on a treadmill for the treadmill exercise test until:

A
  • Maximally tolerated claudication symptoms occur
  • Test must be stopped secondary to other cause (SOB, chest pain, joint pain, etc.)
  • If neither of the above occur, then test stopped when patient reaches high functioning end point
38
Q

interpretation of treadmill exercise test procedure

A

After walking, patient resumes supine position and ABI measurements taken every 1-2 min until they reach pre-exercise level

A decrease in ABI of >20% immediately following exercise is diagnostic of PAD

39
Q
  • Can obtain more specific information than ABI alone
  • Cuffs placed on: Thigh (upper and lower), Calf, Ankle, Transmetatarsal region of foot, Digit
  • Using a Doppler probe, the pressure at each segment is measured

what noninvasive imaging is this

A

Segmental Limb Pressure

40
Q

interpretation of Segmental Limb Pressure

A

decrease between two consecutive levels of >30 mmHg suggests arterial disease of the artery proximal to the cuff

41
Q
  • Use of ultrasound to map blood flow through lower extremities
  • Determines severity of disease (stenosis vs occlusion) and confirming PE findings
  • Useful if intervention is being considered to assess risk/benefit ratio
  • Should have minimal role in screening pts

what noninvasive imaging is this

A

Arterial Duplex

42
Q
  • Excellent arterial picture
  • No ionizing radiation
  • Non-iodine-based intravenous contrast medium rarely causes renal insufficiency or allergic reaction
  • Not used for screening! Should be considered when surgical intervention is considered

what noninvasive imaging is this

A

Magnetic Resonance Angiography (MRA)

43
Q

Magnetic Resonance Angiography (MRA) is not a good option for these types of pts

A

claustrophobia
pacemaker/implantable cardioverter-defibrillator
obesity

44
Q

Use of gadolinium in patients with chronic kidney disease can result in ?

A

nephrogenic systemic fibrosis (NSF)

Gadolinium cannot be used if GFR < 30 ml/min

45
Q
  • Requires iodinated contrast
  • Requires ionizing radiation
  • Produces an excellent arterial picture
  • Not used for screening! Should be considered when surgical intervention is considered

what noninvasive imaging is this

A

Computed Tomographic Angiography (CTA)

46
Q

Gold standard for peripheral vascular imaging

A

Digital Subtraction Angiography (DSA)

Used primarily to guide intervention

47
Q

Risk Factor Modification for PAD

A
  • Antiplatelet therapy
  • Smoking Cessation
  • Lipid-lowering therapy
  • Glycemic control
  • Blood pressure control
  • Diet and exercise
  • Obesity

PAD is a coronary heart disease risk equivalent

48
Q

TX for PAD

A
  1. Antiplatelets - ASA/Clopidogrel
    - sx atherosclerotic LE PAD
    - asx pt with PAD
    - asx pt with borderline ABI
  2. smoking cessation
  3. ACEI
  4. Statin
  5. Glucose control in DM
  6. Specific PAD pharm - Cilostazol (Pletal)
  7. Exercise therapy for intermittent claudication
  8. Invasive tx
    - surgical bypass
    - Endovascular Therapy
49
Q

smoking cessation is recommended for PAD as it decreases the likelihood of:

A
  • Amputation
  • Need for revascularization
  • Failure of arterial bypass grafts

Improves pain-free and maximal walking times
Improves survival

50
Q

indications for Cilostazol (Pletal)

A

Effective therapy to improve sx (Class I, LOE A) - Improves claudication distance by 40-60%

51
Q

MOA of cilostazol (pletal)

A

Has vasodilator & antiplatelet properties

  1. inhibits phosphodiesterase activity and suppress degradation of cAMP resulting in an increase in cAMP in platelets and blood vessels
    - reversibly inhibits platelet aggregation induced by ADP, collagen, arachidonic acid, epinephrine, thromboxane A2, platelet activating factor, and shear stress
    - vasodilation, with greater dilation in femoral beds than in vertebral, carotid, or superior mesenteric arteries, but without effect in renal arteries
52
Q

CI of Cilostazol (Pletal)

A

heart failure of any severity

53
Q

SE of Cilostazol (Pletal)

A

edema, GI upset, dizziness, HA, palpitations, bleeding

54
Q

PK of Cilostazol (Pletal)

A
  • No dose adjustments for CKD or liver failure
  • protein bound → advised to take drug 30 min before or 2 h after a meal
55
Q

Exercise Therapy for Intermittent Claudication

A
  • Aimed at improving walking distance and quality of life
  • Frequency: 3-5 supervised sessions/week
  • Duration: 35 to 50 minutes of exercise/session
  • Type of exercise: treadmill or track walking to near-maximal claudication pain
  • Length: 6 months or more
  • Results: 100%-150% improvement in maximal walking distance
56
Q

Bypass grafts with prosthetic material or native veins has good long-term outcomes with durability

what invasive PAD tx is this

A

Surgical Bypass

57
Q

Ways for Endovascular Therapy

A
  1. Multiple treatment strategies available
    - Angioplasty
    - Stenting
    - Atherectomy
58
Q

indications for invasive PAD tx?

A

Surgical Bypass & Endovascular Therapy

continued intermittent claudication sx’s despite other therapies or in patients with critical limb ischemia